Telemetry Investments’s KalVista Pharmaceuticals KALV Stock Holding History

Telemetry Investments’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,883	Closed	-$491K	–	138
2018 Q4	$491K	Buy	24,883 +8,883	+56%	+$179K	0.66%	76
2018 Q3	$354K	Sell	16,000 -39,104	-71%	-$529K	0.53%	74
2018 Q2	$447K	Buy	+55,104	New	+$486K	0.54%	65

Other funds holding KALV

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return